3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Lip Diseases: new trials by email Literature Review of Lip Diseases trials Research Report on Lip Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection HDIT101 (blinded therapy), Placebo (blinded therapy), Photo documentation of orolabial herpes lesions - Herpes Labialis | Phase 2 | Terminated | Heidelberg ImmunoTherapeutics GmbH | 761 | 2020-10-08 | 2023-09-25 |
| A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis Squaric Acid Dibutyl Ester - Herpes Labialis, HSV | Phase 2 | Terminated | Squarex, LLC | 40 | 2018-03-12 | 2021-08-06 |
| A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis Glutamine, Glycine - Herpes Labialis, Herpes Simplex Virus | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 11 | 2009-06-01 | 2012-06-11 |
Herpes Labialis (3) · Herpes Simplex (1)
DNA Virus Infections (3) · Herpesviridae Infections (3) · Infections (3) · Mouth Diseases (3) · Skin Diseases (3) · Skin Diseases, Infectious (3) · Skin Diseases, Viral (3) · Skin and Connective Tissue Diseases (3) · Stomatognathic Diseases (3) · Virus Diseases (3) · Herpes Simplex (2)
Glutamine (1) · Glycine (1) · Patient Reported Outcome Measures (1) · squaric acid dibutyl ester (1)
Heidelberg ImmunoTherapeutics GmbH (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Squarex, LLC (1)
United States (2) · Germany (1)